CRISPR-mediated Regulation of Human Myogenesis + Disease

June 14, 2024


The goal of this interactive discussion was to sustain the ongoing discourse regarding the utilization of CRISPR/Cas9 in conjunction with older technologies in order to reimagine gene and cell therapy treatments, particularly for Duchenne Muscular Dystrophy (DMD).

Agenda

Moderator: Graca Almeida-Porada, MD, PhD (Wake Forest University)

Speaker: April Pyle, PhD

Dr. Pyle is Professor and Vice Chair in the Department of Microbiology, Immunology and Molecular Genetics (MIMG), and a member of the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research (BSCRC) at UCLA.

2024

Register for the ASGCT Policy Summit

September 23-24, 2024 | Washington, D.C.

This site uses cookies to offer you a better user experience and to analyze site traffic. By continuing to use this website, you accept our use of cookies.